End of Life After Transcatheter Aortic Valve Replacement: A Danish Nationwide Cohort Study

Heart, Artery and Coronary DiseasesFurther Publications

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Clin Res Cardiol

Saad M, Seoudy H, Bramlage K, Bramlage P, Voran JC, Puehler T, Lutter G, Allali A, Landt M, Frank J, Bisht O, Salem M, Wienemann H, Adam M, Zeus T, Veulemans V, Bleiziffer S, Rudolph TK, Frank D

doi: 10.1007/s00392-025-02611-w

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study

Lancet

Makkar RR, Thourani VH, Vahl TP, Yadav PK, McCabe JM, George I, Satler L, Chetcuti S, Daniels DV, Waggoner T, Whisenant B, Russo M, Summers M, Garcia S, Frisoli T, Ramana RK, Stinis C, Golwala H, Zahr F, Greenbaum A, Rovin J, Sanchez C, Szerlip M, Deeb GM, Amoroso N, Patel D, Fahy M, Ranard LS, Gupta A, Chakravarty T, Skaf S, Chuang M, Kodali SK, Figulla HR, Treede H, Baldus S, Pinto DS, Leon MB, ALIGN-AR Investigators

doi: 10.1016/S0140-6736(25)02215-9

Heart, Artery and Coronary DiseasesTherapy and Intervention

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators

doi: 10.1016/j.jacc.2025.03.004

Heart, Artery and Coronary DiseasesTherapy and Intervention

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement. The PROMOTE Study

Heart Rhythm

Rodés-Cabau J, Nombela-Franco L, Muntané-Carol G, Veiga G, Regueiro A, Nazif T, Serra V, Asmarats L, Ribeiro HB, Latib A, Poulin A, Cheema AN, Jiménez-Quevedo P, Gomez-Hospital JA, Ongay AG, Gabani R, Arzamendi D, Brener M, Calabuig A, Scotti A, Gelain MAS, Labinaz M, Cepas P, Nuche J, Côté M, Del Portillo JH, Philippon F

doi: 10.1016/j.hrthm.2024.12.019

Heart, Artery and Coronary DiseasesTherapy and Intervention

Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts

Heart

Tomsic A, Velders BJJ, Kawczynski MJ, Schoones JW, Klautz RJM, Palmen M, Sardari Nia P, Owais T, Girdauskas E, Heuts S

doi: 10.1136/heartjnl-2025-326162

Heart, Artery and Coronary DiseasesTherapy and Intervention

Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement: The SwissTAVI Registry

JACC Cardiovasc Interv

Badertscher P, Stortecky S, Serban T, Knecht S, Heg D, Tueller D, Jeger R, Reuthebuch O, Muller O, Toggweiler S, Wenaweser P, Huber C, Roffi M, Ferrari E, Reichlin T, Nestelberger T, Mahfoud F, Kühne M, Sticherling C, SwissTAVI Investigators

doi: 10.1016/j.jcin.2025.03.028

Heart, Artery and Coronary DiseasesTherapy and Intervention

SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial

Lancet

Terkelsen CJ, Freeman P, Dahl JS, Thim T, Nørgaard BL, Mogensen NSB, Tang M, Eftekhari A, Povlsen JA, Poulsen SH, Pedersen L, Hjort J, Ellert J, Christiansen EH, Sørensen HT, Nissen H

doi: 10.1016/S0140-6736(25)00106-0

Heart, Artery and Coronary Diseases

Five-year outcomes of transcatheter versus surgical aortic valve replacement in women: A systematic review and meta-analysis

Eur J Cardiothorac Surg

Wolf SEM, Kucera JA, Gregg AC, Di Franco A, Rahouma M, Redfors B, Reardon M, Pineda AM, Gaca JA, Zwischenberger BA

doi: 10.1093/ejcts/ezaf400

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial

Eur Heart J

Tchetche D, Pibarot P, Bax JJ, Bonaros N, Windecker S, Dumonteil N, Nietlispach F, Messika-Zeitoun D, Pocock SJ, Berthoumieu P, Swaans MJ, Timmers L, Rudolph TK, Bleiziffer S, Leroux L, Modine T, van der Kley F, Auffret V, Tomasi J, Stastny L, Hengstenberg C, Andreas M, Leclercq F, Gandet T, Mascherbauer J, Trescher K, Prendergast B, Vasa-Nicotera M, Chieffo A, Mares J, Wesselink W, Rakova R, Kurucova J, Bramlage P, Eltchaninoff H

doi: 10.1093/eurheartj/ehaf133

Related content

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement. The PROMOTE Study

Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts

Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement: The SwissTAVI Registry

SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial

Five-year outcomes of transcatheter versus surgical aortic valve replacement in women: A systematic review and meta-analysis

Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial